Synergene Therapeutics Inc.
Annapolis, MD
- UEI
- W8E3G5851JK4
- CAGE
- 43DC1
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1216 River Bay Rd, Annapolis, MD 21409, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Application of a nanocomplex technology to the active permeation of the blood brain barrier (BBB) | Defense Threat Reduction Agency | $7,589,344 | |
| R & d- medical: biomedical (basic research) | National Cancer Institute | $222,900 | |
| In delivered nanomedicine crossing the BBB continuously makes highly active bche. | Defense Threat Reduction Agency | $5,083,968 | |
| Targeted nanocomplexed iron oxide for early detection with hyperthermia treatment of cancer | National Cancer Institute | $199,735 | |
| Sbir proposal for PHS 2009-1 topic 266 for a targeted nanocomplix for early detection of lung cancer | National Cancer Institute | $1,196,639 |
Quick answers
What is Synergene Therapeutics Inc.'s UEI?
Synergene Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is W8E3G5851JK4.
What is Synergene Therapeutics Inc.'s CAGE code?
Synergene Therapeutics Inc.'s CAGE code is 43DC1.
What is Synergene Therapeutics Inc.'s primary NAICS code?
Synergene Therapeutics Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Synergene Therapeutics Inc. located?
Synergene Therapeutics Inc.'s physical address in SAM.gov is 1216 River Bay Rd, Annapolis, MD 21409, USA.
Is Synergene Therapeutics Inc. registered in SAM.gov?
Yes. Synergene Therapeutics Inc.'s SAM.gov registration is active through June 26, 2027.
What is Synergene Therapeutics Inc.'s most recent federal award?
Synergene Therapeutics Inc.'s most recent federal contract award is Application of a nanocomplex technology to the active permeation of the blood brain barrier (BBB) (HDTRA120C0045), from Defense Threat Reduction Agency, on July 7, 2020.
On GovTribe
See Synergene Therapeutics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors